Study of Brain Imaging Scores to Predict Recovery After Acute Ischemic Stroke Treated with Clot-Busting Medicine and Clot Removal

What this Trial Is About

Researchers are evaluating patients who have experienced acute ischemic stroke and were treated with clot-busting medicine thrombolysis and a procedure to remove the clot thrombectomy. Despite these treatments, about half of patients do not fully recover. The study aims to determine if certain brain imaging scores, alone or combined, can better predict patient recovery 90 days after stroke and the success of blood vessel reopening. This observational study will include 152 patients and is sponsored by Centre Hospitalier de Gonesse. The study involves observing patients who received both thrombolysis and thrombectomy after an acute ischemic stroke. There are no additional treatments or interventions given as part of the study. Instead, the researchers will analyze brain imaging and clinical data collected during routine care to assess how well the imaging scores predict recovery outcomes. Participants will be followed for about 90 days after their stroke. Researchers will collect clinical follow-up data, including the modified Rankin Scale mRS score at 90 days, to measure recovery. The main outcome is a favorable functional outcome defined as an mRS score of 0 to 2 at 90 days. The study aims to find simple and reliable tools to help doctors make better treatment decisions in the future.

Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke